Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Liraglutide acts faster but requires daily dosing, while tirzepatide targets an additional hormone pathway that may make it more potent for weight loss
Semaglutide, like other GLP-1 Ras, is used for the treatment of obesity and has seen tremendous increase in utilization over the last few years, even making its way into workers comp
It may increase the risk of pancreatitis (a rare but serious side effect of tirzepatide), can worsen gastrointestinal symptoms, and may increase hypoglycemia risk in patients also taking insulin or sulfonylureas
Multiple liver transplant cases documented at supratherapeutic doses (6-9 grams/day) with fetal death
"Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial." New England Journal of Medicine , 2023;389:514-526
US$ 28.52
US$ 29.39
US$ 22.10
US$ 29.74
US$ 24.25
US$ 24.42
